These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9761361)

  • 41. Acute renal failure in the pediatric patient.
    Mendley SR; Langman CB
    Adv Ren Replace Ther; 1997 Apr; 4(2 Suppl 1):93-101. PubMed ID: 9113245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors affecting urea clearance during continuous hemodiafiltration in the canine model.
    Hiyama DT; Weiss RG; Ryckman FC
    J Pediatr Surg; 1989 Aug; 24(8):756-9. PubMed ID: 2769542
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ECMO as a Platform for Rapid Ammonia Removal in a Neonate with Multienzyme Urea Cycle Disorder.
    Ikeri K; Cardona VQ; Hagan-Brown A; Young M; Schneider M; Menkiti O
    J Extra Corpor Technol; 2020 Mar; 52(1):58-62. PubMed ID: 32280145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Continuous venovenous hemodiafiltration in the treatment of acute hyperammonemia.
    Braun MC; Welch TR
    Am J Nephrol; 1998; 18(6):531-3. PubMed ID: 9845830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phenylacetate and benzoate clearance in a hyperammonemic infant on sequential hemodialysis and hemofiltration.
    Bunchman TE; Barletta GM; Winters JW; Gardner JJ; Crumb TL; McBryde KD
    Pediatr Nephrol; 2007 Jul; 22(7):1062-5. PubMed ID: 17277951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Removal of amino acids by continuous hemofiltration and hemodiafiltration].
    Gouyon JB; Françoise M; Desgres J; Petion AM; Sandre D
    Arch Pediatr; 1994 May; 1(5):501-4. PubMed ID: 7951837
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aminograms during continuous hemodiafiltration in the treatment of hyperammonemia due to ornithine transcarbamylase deficiency.
    Chen CY; Tsai TC; Lee WJ; Chen HC
    Ren Fail; 2007; 29(6):661-5. PubMed ID: 17763159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of ammonia levels and dialysis on outcome in 202 patients with neonatal onset urea cycle disorders.
    Hediger N; Landolt MA; Diez-Fernandez C; Huemer M; Häberle J
    J Inherit Metab Dis; 2018 Jul; 41(4):689-698. PubMed ID: 29520739
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Continuous veno-venous hemodiafiltration for the treatment of spontaneous tumor lysis syndrome complicated by acute renal failure and severe hyperuricemia.
    Agha-Razii M; Amyot SL; Pichette V; Cardinal J; Ouimet D; Leblanc M
    Clin Nephrol; 2000 Jul; 54(1):59-63. PubMed ID: 10939758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A prospective comparative study of continuous arteriovenous hemodiafiltration and continuous venovenous hemodiafiltration in critically ill patients.
    Bellomo R; Parkin G; Love J; Boyce N
    Am J Kidney Dis; 1993 Apr; 21(4):400-4. PubMed ID: 8465820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The utility of EEG monitoring in neonates with hyperammonemia due to inborn errors of metabolism.
    Wiwattanadittakul N; Prust M; Gaillard WD; Massaro A; Vezina G; Tsuchida TN; Gropman AL
    Mol Genet Metab; 2018 Nov; 125(3):235-240. PubMed ID: 30197275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Continuous venovenous haemofiltration in the acute treatment of inborn errors of metabolism.
    Falk MC; Knight JF; Roy LP; Wilcken B; Schell DN; O'Connell AJ; Gillis J
    Pediatr Nephrol; 1994 Jun; 8(3):330-3. PubMed ID: 7917860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An analytical solution to solute transport in continuous arterio-venous hemodiafiltration (CAVHD).
    Akcahuseyin E; van Duyl WA; Vos MC; Vincent HH
    Med Eng Phys; 1996 Jan; 18(1):26-35. PubMed ID: 8771036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal replacement therapy after repair of congenital heart disease in children. A comparison of hemofiltration and peritoneal dialysis.
    Fleming F; Bohn D; Edwards H; Cox P; Geary D; McCrindle BW; Williams WG
    J Thorac Cardiovasc Surg; 1995 Feb; 109(2):322-31. PubMed ID: 7853885
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ability of a novel system for neonatal extracorporeal renal replacement therapy with an ultra-small volume circuit to remove solutes in vitro.
    Nishimi S; Ishikawa K; Sasaki M; Furukawa H; Takada A; Chida S
    Pediatr Nephrol; 2016 Mar; 31(3):493-500. PubMed ID: 26493070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of tumor lysis syndrome with standard continuous arteriovenous hemodialysis: case report and a review of the literature.
    Schelling JR; Ghandour FZ; Strickland TJ; Sedor JR
    Ren Fail; 1998 Jul; 20(4):635-44. PubMed ID: 9713883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transient hyperammonemia of the preterm infant.
    Ballard RA; Vinocur B; Reynolds JW; Wennberg RP; Merritt A; Sweetman L; Nyhan WL
    N Engl J Med; 1978 Oct; 299(17):920-5. PubMed ID: 692597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Solute clearances with high dialysate flow rates and glucose absorption from the dialysate in continuous arteriovenous hemodialysis.
    Bonnardeaux A; Pichette V; Ouimet D; Geadah D; Habel F; Cardinal J
    Am J Kidney Dis; 1992 Jan; 19(1):31-8. PubMed ID: 1739079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ornithine transcarbamylase deficiency: case report and review.
    Bueno JD; Lutz R; Cho S
    Kans Med; 1995; 96(3):135-8. PubMed ID: 8583741
    [No Abstract]   [Full Text] [Related]  

  • 60. [Efficacy of various therapeutic measures in metabolic hyperammonemia].
    Pérez Rodríguez MJ; Vázquez Martínez JL; Martínez-Pardo Casanova M; Martos Sánchez I; Lozano Jiménez C; Gallego Cobos N
    An Esp Pediatr; 1997 May; 46(5):460-3. PubMed ID: 9297399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.